Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 13Advanced Solid Tumors 6Solid Tumors 5Advanced Solid Tumor 5Solid Tumor 4Mesothelioma 2Triple Negative Breast Neoplasms 1Thymoma 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Retinoblastoma 1Resectable Colon Cancer 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1Malignant Solid Tumour 1MSI-H Advanced Colorectal Cancer 1Esophageal Neoplasms 1Endometrial Neoplasms 1Choroid Plexus Neoplasms 1Childhood Central Nervous System Choriocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Nivolumab 3pembrolizumab 2Ipilimumab 2tislelizumab 1spartalizumab 1regorafenib 1epacadostat 1cabozantinib 1Pemetrexed 1Paclitaxel 1Levoleucovorin 1Leucovorin 1Exercise 1Docetaxel 1Clinical Trials, Phase II as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Transitional Cell × Leucovorin × Other solid neoplasm × Clear all
NCT05714553 2025-07-18

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

NuCana plc

Phase 1/2 Terminated
19 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Esophageal Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡